Edwards Lifesciences Corp (NYSE:EW) over-valued by 12%
Website | https://www.edwards.com |
Sector | Healthcare |
Industry | Medical Devices |
Fiscal Year End | Dec 31, 2020 |
Market Cap | $59,242,704,896 |
Beta | 0.89386 |
Average Volume | $2,752,066 |
Last Dividend | 0% |
Price on Feb 12, 2021 | $95.24 |
Autochartist™ Valuation | $83.95 |
Conclusion |
12% over-valued |
Download Report |